These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10509868)

  • 1. Phosphoinositide signalling system in platelets of schizophrenic patients and the effect of neuroleptic therapy.
    Rípová D; Strunecká A; Platilová V; Höschl C
    Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):125-9. PubMed ID: 10509868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol phospholipid turnover in platelets of schizophrenic patients.
    Das I; Essali MA; de Belleroche J; Hirsch SR
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):65-6. PubMed ID: 1352897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased turnover of platelet phosphatidylinositol in schizophrenia.
    Yao JK; Yasaei P; van Kammen DP
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):39-46. PubMed ID: 1352896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment.
    Essali MA; Das I; de Belleroche J; Hirsch SR
    Biol Psychiatry; 1990 Sep; 28(6):475-87. PubMed ID: 1977477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol phospholipid metabolism in human platelets stimulated by ADP.
    Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Eur J Biochem; 1990 Oct; 193(2):521-8. PubMed ID: 2171937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated platelet phosphatidylinositol bisphosphate in mediated schizophrenics.
    Das I; Essali MA; de Belleroche J; Hirsch SR
    Schizophr Res; 1994 Jun; 12(3):265-8. PubMed ID: 7914431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide signalling system in red blood cells of patients with hereditary spherocytosis.
    Strunecká A; Krpejsová L; Kmonícková E; Hrůsová H; Jakoubková H; Marík T; Brabec V
    Biomed Biochim Acta; 1991; 50(1):93-100. PubMed ID: 1650191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activity and phosphoinositide turnover increase with advancing age.
    Bastyr EJ; Kadrofske MM; Vinik AI
    Am J Med; 1990 Jun; 88(6):601-6. PubMed ID: 2161185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipids and calcium alterations in platelets of schizophrenic patients.
    Rípová D; Strunecká A; Nemcová V; Farská I
    Physiol Res; 1997; 46(1):59-68. PubMed ID: 9728523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of phosphoinositides in human platelets.
    Suga K; Kambayashi J; Kawasaki T; Sakon M; Mori T
    Thromb Res; 1986 Oct; 44(2):155-63. PubMed ID: 3024354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients.
    Ishii H; Umeda F; Hashimoto T; Nawata H
    Diabetes; 1990 Dec; 39(12):1561-8. PubMed ID: 2174010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
    Ryningen A; Olav Jensen B; Holmsen H
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet phosphoinositide turnover in streptozotocin-induced diabetes.
    Jethmalani SM; Dang AQ; Faas FH
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jun; 50(6):339-46. PubMed ID: 7938087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
    Steen VM; Tysnes OB; Holmsen H
    Biochem J; 1988 Jul; 253(2):581-6. PubMed ID: 2845924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
    Bastyr EJ; Kadrofske MM; Dershimer RC; Vinik AI
    Diabetes; 1989 Sep; 38(9):1097-102. PubMed ID: 2548908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chlorpromazine on inositol-lipid signalling system in human thrombocytes.
    Strunecká A; Rípová D; Folk P
    Physiol Bohemoslov; 1987; 36(6):495-501. PubMed ID: 2830631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of inositol 1,4,5-trisphosphate-induced calcium release by inositol 1,4,5-trisphosphate and calcium in human platelets.
    Eberhard M; Erne P
    J Recept Signal Transduct Res; 1995; 15(1-4):297-309. PubMed ID: 8903946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us?
    Strunecká A; Rípová D
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):1-5. PubMed ID: 10477034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal phosphatidylinositol-cycle of platelet membrane in schizophrenia--a preliminary study.
    Kaiya H; Takeuchi K; Namba M; Imai A; Nakashima S; Nozawa Y
    Folia Psychiatr Neurol Jpn; 1984; 38(4):437-44. PubMed ID: 6152585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis?
    Kaiya H; Nishida A; Imai A; Nakashima S; Nozawa Y
    Biol Psychiatry; 1989 Nov; 26(7):669-76. PubMed ID: 2553139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.